Cholestasis Ppt and 100 Published articles free

Cholestasis is any condition in which the flow of bile from the liver is blocked.

Medical Nutrition Therapy for Liver, Biliary System, and Exocrine Pancreas Disorders
Liver.ppt

Jaundice
Hilary Sanfey, MD
jaundice.pps

ERCP in the Pediatric Population
Ross Goshorn
ERCP in the Pediatric Population.ppt

GI & Liver Disease in Pregnancy
C. Brock Miller, MD
GI & Liver Disease in Pregnancy.ppt

Method of Monitoring
Liver, Coagulation, & Endocrine
Liver_coag_endocrine.ppt

Intrahepatic Cholestasis of Pregnancy
Method of Monitoring.ppt

Cholestatic Liver Disease
CholestaticLiverDiseasejaundicewithCholangiocarcinomafocus.ppt

Tests for Detecting Cholestasis
Tests for Detecting Cholestasis.ppt

Primary Biliary Cirrhosis (PBC)
Thomas W. Faust, M.D., M.B.E.
PBC.ppt
100 free published articles

1. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort.
2. Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.
3. Coinfection of hepatitis A virus genotype IA and IIIA complicated with autoimmune hemolytic anemia, prolonged cholestasis, and false-positive immunoglobulin M anti-hepatitis E virus: a case report.
4. Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis.
5. Intrahepatic cholestasis of pregnancy: correlation of preterm delivery with bile acids.
6. Neonatal cholestasis in congenital pituitary hormone deficiency and isolated hypocortisolism: characterization of liver dysfunction and follow-up.
7. Intestinal nuclear bile acid receptor FXR and cholestasis.
8. Increased liver stiffness in extrahepatic cholestasis caused by choledocholithiasis.
9. Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis.
10. Cholestasis as the initial presentation of relapsing polychondritis.
11. Proteomic analysis of polypeptides captured from blood during extracorporeal albumin dialysis in patients with cholestasis and resistant pruritus.
12. The effects of L-arginine on liver damage in experimental acute cholestasis an immunohistochemical study.
13. Expression of cytokeratin 7 as a histological marker of cholestasis and stages of primary biliary cirrhosis.
14. [Neonatal cholestasis and hypoglycemia like form of congenital hypopituitarism presentation].
15. Hyperbaric oxygenation promotes regeneration of biliary cells and improves cholestasis in rats.
16. Comment on: Early cholestasis in neonatal lupus erythematosus. Ann Saudi Med 2011; 31: 80-2.
17. Orthotopic liver transplantation in a pediatric patient with progressive intrahepatic cholestasis: a coordinated perioperative subspecialty approach.
18. Partial internal biliary diversion: a solution for intractable pruritus in progressive familial intrahepatic cholestasis type 1.
19. X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C.
20. [SLC25A13 gene analysis in neonates with intrahepatic cholestasis caused by citrin deficiency].
21. Intrahepatic cholestasis in sickle cell disease: a case report.
22. Drug-induced cholestasis.
23. Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice.
24. Cholestasis in patients with Cockayne syndrome and suggested modified criteria for clinical diagnosis.
25. [Transient neonatal cholestasis].
26. Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series.
27. Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.
28. Study of adiponectin in chronic liver disease and cholestasis.
29. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.
30. A gentleman with anemia and cholestasis.
31. Normal levels of serum pancreatic enzymes in patients with progressive familial intrahepatic cholestasis type 2.
32. Progressive familial intrahepatic cholestasis.
33. Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis.
34. Itraconazole-induced cholestasis: involvement of the inhibition of bile canalicular phospholipid translocator MDR3/ABCB4.
35. The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis.
36. Langerhans cell histiocytosis: a rare cause of cholestasis in adult patients. Case report.
37. Early cholestasis in neonatal lupus erythematosus.
38. Clinical features differentiating biliary atresia from other causes of neonatal cholestasis.
39. Syndrome of inappropriate secretion of antidiuretic hormone cholestasis and pericardial effusion due to brucellosis infection: a case report.
40. [Niemann-Pick type C disease: From neonatal cholestasis to neurological degeneration. Different phenotypes].
41. Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis.
42. Cholecystoappendicostomy for progressive familial intrahepatic cholestasis.
43. Role of breast cancer resistance protein in the adaptive response to cholestasis.
44. Aetiology and outcome of neonatal cholestasis in Malaysia.
45. Recurrent low gamma-glutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease).
46. Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation.
47. Progressive familial intrahepatic cholestasis (PFIC) type 3 in two Sicilian siblings of nonconsanguineous parents.
48. Selectively high levels of serum interleukin 17 in a newborn infant with progressive severe cholestasis.
49. Liver disease without flipping: new functions of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1.
50. Most common SLC25A13 mutation in 400 Chinese infants with intrahepatic cholestasis.
51. [Expression of HLA-G protein in placental tissues and its influence on Th1/Th2 cytokines in peripheral blood in patients with intrahepatic cholestasis of pregnancy].
52. Low γ-GT Familial Intrahepatic Cholestasis.
53. Pancreatic adenocarcinoma in type 2 progressive familial intrahepatic cholestasis.
54. Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis.
55. Neonatal intrahepatic cholestasis caused by citrin deficiency in two Malaysian siblings: outcome at one year of life.
56. Corticotropin-releasing hormone receptors mediate opposing effects in cholestasis-induced liver cell apoptosis.
57. There may be a link between intrahepatic cholestasis of pregnancy and familial combined hyperlipidaemia: a case report.
58. Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis.
59. [Glucocorticoid treatment for early postoperative cholangiole cholestasis hyperbilirubinemia after liver transplantation].
60. Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis.
61. Differential diagnosis of neonatal cholestasis: clinical and laboratory parameters.
62. Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human.
63. [Effect of intrahepatic cholestasis of pregnancy on the functions of hypothalamic-pituitary-adrenocortical axis and adrenal cortex in normal neonates].
64. A novel DHCR7 mutation in a Smith-Lemli-Opitz syndrome infant presenting with neonatal cholestasis.
65. Multidrug resistance protein 3 R652G may reduce susceptibility to idiopathic infant cholestasis.
66. Potential role of everolimus in inducing cholestasis.
67. Altered expression of nuclear receptors affects the expression of metabolic enzymes and transporters in a rat model of cholestasis.
68. Alteration of methotrexate biliary and renal elimination during extrahepatic and intrahepatic cholestasis in rats.
69. Usefulness of a scoring system in the interpretation of histology in neonatal cholestasis.
70. Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis.
71. [Progressive familial intrahepatic cholestasis presenting as liver failure].
72. Inhibition of nitric oxide synthesis during induced cholestasis ameliorates hepatocellular injury by facilitating S-nitrosothiol homeostasis.
73. [Genetic cholestasis].
74. Novel ABCB11 mutations in a Thai infant with progressive familial intrahepatic cholestasis.
75. Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis.
76. Neonatal cholestasis. A rare complication of fetal tachycardia.
77. The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis.
78. Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling.
79. Use of di(2-ethylhexyl)phthalate-containing infusion systems increases the risk for cholestasis.
80. IGF-1R contributes to stress-induced hepatocellular damage in experimental cholestasis.
81. [Stevens-Johnson syndrome plus intrahepatic cholestasis caused by clindamycin or chlorpheniramine].
82. Cytomegalovirus frequency in neonatal intrahepatic cholestasis determined by serology, histology, immunohistochemistry and PCR.
83. [Cholestasis and cholestatic liver diseases].
84. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.
85. Liver transplantation for progressive familial intrahepatic cholestasis: the evolving role of genotyping.
86. Concurrent course of transient neonatal diabetes with cholestasis and paucity of interlobular bile ducts: a case report.
87. Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis.
88. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid].
89. Intrahepatic cholestasis of pregnancy.
90. Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications.
91. The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients.
92. [Clinical case: management of chronic cholestasis].
93. Intrahepatic cholestasis of pregnancy: when should you look further?
94. In vivo dynamic metabolic imaging of obstructive cholestasis in mice.
95. Intrahepatic cholestasis without jaundice.
96. Opioid antagonist for pruritus of cholestasis unmasking bony metastases.
97. [Effect of cholestasis on renal morphological and functional aspects after nephrectomy].
98. ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling.
99. Mechanisms of resistance of hepatocyte retinoid X receptor alpha-null mice to WY-14,643-induced hepatocyte proliferation and cholestasis.
100. Simvastatin protects against cholestasis-induced liver injury.